Virtue Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,511	Closed	-$658K	–	419
2022 Q4	$658K	Buy	+5,511	New	+$658K	0.1%	147